Wilbanks Smith & Thomas Asset Management LLC increased its holdings in Cerner Co. (NASDAQ:CERN) by 3.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 40,043 shares of the company’s stock after purchasing an additional 1,456 shares during the quarter. Wilbanks Smith & Thomas Asset Management LLC’s holdings in Cerner were worth $2,394,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in Cerner by 5.1% during the second quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 17,207 shares of the company’s stock valued at $1,029,000 after acquiring an additional 841 shares during the last quarter. Public Employees Retirement Association of Colorado boosted its position in Cerner by 1.6% during the second quarter. Public Employees Retirement Association of Colorado now owns 54,804 shares of the company’s stock valued at $3,277,000 after acquiring an additional 849 shares during the last quarter. CENTRAL TRUST Co boosted its position in Cerner by 8.8% during the second quarter. CENTRAL TRUST Co now owns 11,035 shares of the company’s stock valued at $660,000 after acquiring an additional 891 shares during the last quarter. Sentry Investment Management LLC boosted its position in shares of Cerner by 4.0% during the 1st quarter. Sentry Investment Management LLC now owns 23,112 shares of the company’s stock worth $1,340,000 after purchasing an additional 896 shares in the last quarter. Finally, TCW Group Inc. boosted its position in shares of Cerner by 6.9% during the 1st quarter. TCW Group Inc. now owns 13,869 shares of the company’s stock worth $804,000 after purchasing an additional 900 shares in the last quarter. 80.38% of the stock is currently owned by institutional investors.

CERN stock opened at $64.86 on Friday. The stock has a market cap of $21.44 billion, a PE ratio of 29.48, a P/E/G ratio of 2.06 and a beta of 0.98. The company has a current ratio of 2.85, a quick ratio of 2.83 and a debt-to-equity ratio of 0.09. Cerner Co. has a 1 year low of $52.05 and a 1 year high of $73.86.

Cerner (NASDAQ:CERN) last posted its earnings results on Thursday, August 2nd. The company reported $0.62 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.60 by $0.02. Cerner had a net margin of 16.06% and a return on equity of 15.26%. The company had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the business posted $0.61 EPS. The firm’s revenue was up 5.9% compared to the same quarter last year. sell-side analysts expect that Cerner Co. will post 2.28 EPS for the current fiscal year.

In related news, Vice Chairman Clifford W. Illig sold 205,600 shares of the company’s stock in a transaction dated Thursday, June 7th. The shares were sold at an average price of $60.26, for a total value of $12,389,456.00. Following the sale, the insider now owns 1,229,719 shares in the company, valued at approximately $74,102,866.94. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Vice Chairman Clifford W. Illig sold 378,900 shares of the company’s stock in a transaction dated Thursday, August 9th. The stock was sold at an average price of $66.46, for a total transaction of $25,181,694.00. Following the completion of the sale, the insider now owns 1,229,719 shares in the company, valued at approximately $81,727,124.74. The disclosure for this sale can be found here. Insiders sold a total of 659,648 shares of company stock worth $42,184,489 in the last 90 days. 4.71% of the stock is currently owned by company insiders.

A number of research firms have recently issued reports on CERN. Stifel Nicolaus cut their price objective on shares of Cerner from $71.00 to $62.00 and set a “hold” rating on the stock in a research report on Thursday, May 3rd. Canaccord Genuity cut their price objective on shares of Cerner from $73.00 to $64.00 and set a “buy” rating on the stock in a research report on Thursday, May 3rd. SunTrust Banks cut their price objective on shares of Cerner to $58.00 in a research report on Friday, May 4th. BidaskClub raised shares of Cerner from a “sell” rating to a “hold” rating in a research report on Thursday, May 31st. Finally, Jefferies Financial Group set a $70.00 price objective on shares of Cerner and gave the stock a “buy” rating in a research report on Friday, June 1st. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $71.69.

Cerner Profile

Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Featured Story: Growth Stocks

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.